NousCom concludes successful series A financing of EUR 12 million to support discovery and development of personalized cancer vaccines
Basel, Switzerland – May, 17 2016 Nouscom announced today that it has closed a EUR 12 million Series A financing co-led by LSP and Versant Ventures. The funds will be used to support discovery [...]
